Lite Strategy, Inc. Interest Expense, Other
Lite Strategy, Inc. (LITS) reported Interest Expense, Other of $0 for the 3-month period ending 2021-12-31, per its 10-Q/A filed 2022-05-23.
Discontinued › Expense Statement
us-gaap:InterestExpenseOther · last filed 2022-05-23
- Lite Strategy, Inc. interest expense, other for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. interest expense, other for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. interest expense, other for the quarter ending 2020-12-31 was $500.00K.
- Lite Strategy, Inc. interest expense, other for the quarter ending 2020-09-30 was $5.00K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month |
|---|---|---|
| 2021-12-31 | $0.00 10-Q/A · filed 2022-05-23 | $0.00 10-Q/A · filed 2022-05-23 |
| 2021-09-30 | $0.00 10-Q/A · filed 2022-05-23 | |
| 2020-12-31 | $500.00K 10-Q/A · filed 2022-05-23 | $495.00K 10-Q/A · filed 2022-05-23 |
| 2020-09-30 | $5.00K 10-Q/A · filed 2022-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |